Global Primary Cells Market Size By Type (Human Primary Cells and Animal Primary Cells), By Origin (Hematopoietic Cells, Skin Cells, Liver Cells, Renal Cells), By Geographic Scope And Forecast

List of Tables

Primary Cells Market Size And Forecast

Primary Cells Market size was valued at USD 1,015.52 Million in 2020 and is projected to reach USD 2,306.79 Million by 2028, growing at a CAGR of 10.78% from 2021 to 2028.

The demand for primary cells has been growing spontaneously on account of growing research on cancer and the development of possible therapy and treatment. The Global Primary Cells Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Primary Cells Market Definition

Primary Cells refer to sources of primary cell culture that refer to the removal of cells from human or animal sources and maintaining them to divide them. They are taken from the tissue of organisms and processed to establish them for use in optimized culture conditions.

The demand for primary cells is growing in medical research owing to the wide variety of advantages it offers. Primary cells offer better results as compared to other mediums such as cell lines. Mainly primary cell use is cost-effective, moderating the spending on animal experimentation for the in vivo studies.

Global Primary Cells Market Overview

The demand for primary cells has been growing spontaneously on account of growing research on cancer and the development of possible therapy and treatment. Cancer has been the most deadly and persistent type of disease across the globe, with no definite reliable treatment in existence and also, the limited reasons for its occurrence, making its research to be ever continuing and growing since many last decades. The development of biochemistry and medical-related machineries such as stronger microscopes and chemicals have been aiding to expand and widen the scope of cancer research. According to Cancer.org in the last decade, from 2010 to 2020, the instance of the overall cancer related death rate has been declining, mainly owing to the advances in cancer research in terms of how to prevent, treat, diagnose, and survive cancer, driving the growth of cancer research.

The use of primary cells is crucially growing as a major indicator for understanding the effect of cancer cells on the human tissues, without subjecting animals' experimentation through vivo methods. The results of the primary cells are in real time and provide researchers with stronger data, lowering their overall cost of research and increasing the result accuracy.

Global Primary Cells Market: Segmentation Analysis

The Global Primary Cells Market is segmented on the basis of Type, Origin, and Geography.

Primary Cells Market By Type

Human Primary Cells
Animal Primary Cells

Based on Type, the market is bifurcated into Human Primary Cells and Animal Primary Cells. The increasing adoption of human primary cells in developing cancer therapies and the rising funding for the R&D for cell therapies are some of the major factors driving the growth of this segment. In addition to this, the growth of the market is majorly due to the rising Origin of human-derived primary cultures for cancer research. It will likely drive the demand for primary cells segment across the forecast timeline.

Primary Cells Market By Origin

Hematopoietic Cells
Skin Cells
Liver Cells
Renal Cells
Skeletal and Muscle Cells
Others

On the basis of Origin, the Global Primary Cells Market has been segmented into Hematopoietic Cells, Skin Cells, Liver Cells, Renal Cells, Skeletal and Muscle Cells, and Others. Hematopoietic cells segment accounted for the largest market share owing to the rising prevalence of blood cancer and the increasing number of stem cell research projects. They have been used in clinical trials with U.S. FDA oversight for the treatment of autoimmune diseases, genetic diseases, and other indications.

Primary Cells Market By Geography

North America
Europe
Asia Pacific
Rest of the World

On the basis of regional analysis, the Global Primary Cells Market is classified into North America, Europe, Asia Pacific and Rest of the world. North America accounted for the largest market share and Europe was the second-largest in 2019. The growth in this region can be attributed to high healthcare expenditure, a rising incidence of chronic diseases, a growing geriatric population, and supportive government funding. In addition, the key players are focused on innovating cell culture applications, instrumentation, availability of different types of cells, and their cellular interactions are further supporting market growth in the North American region.

Key Players

The "Global Primary Cells Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as - MERCK KGAA, THERMO FISHER SCIENTIFIC, LONZA, Cell Biologics, Inc, Promocell, Axol Biosciences, STEMCELL Technologies Inc, BPS Bioscience, Inc, PPA Research Group, Inc., Bioperdic international and Others. Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

The company announced its merger with CENSO Biotechnologies, cell biology CRO with focused expertise in iPSC-related technologies.
The investment will be used to enable the growth of the business and acquisition of talent to meet customer demand.

Product Code: 28913

1 INTRODUCTION

1.1 MARKET DEFINITION
1.2 MARKET SEGMENTATION
1.3 RESEARCH TIMELINES
1.4 ASSUMPTIONS
1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

2.1 DATA MINING
2.2 SECONDARY RESEARCH
2.3 PRIMARY RESEARCH
2.4 SUBJECT MATTER EXPERT ADVICE
2.5 QUALITY CHECK
2.6 FINAL REVIEW
2.7 DATA TRIANGULATION
2.8 BOTTOM-UP APPROACH
2.9 TOP DOWN APPROACH
2.10 RESEARCH FLOW
2.11 DATA SOURCES

3 EXECUTIVE SUMMARY

3.1 MARKET OVERVIEW
3.2 GLOBAL PRIMARY CELLS MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
3.3 GLOBAL PRIMARY CELLS MARKET, BY TYPE (USD MILLION)
3.4 GLOBAL PRIMARY CELLS MARKET, BY ORIGIN (USD MILLION)
3.5 FUTURE MARKET OPPORTUNITIES
3.6 GLOBAL MARKET SPLIT

4 MARKET OUTLOOK

4.1 GLOBAL PRIMARY CELLS MARKET OUTLOOK
4.2 MARKET DRIVER
- 4.2.1 EXPANDING CANCER RESEARCH AND DEVELOPMENT
4.3 MARKET RESTRAINT
- 4.3.1 HIGH RISK OF CONTAMINATION
4.4 MARKET OPPORTUNITY
- 4.4.1 RISING UTILIZATION OF PRIMARY CELLS IN 3D CELL CULTURES
4.5 IMPACT OF COVID - 19 ON PRIMARY CELLS MARKET
4.6 PORTER'S FIVE FORCES ANALYSIS

5 MARKET, BY TYPE

5.1 OVERVIEW
5.2 HUMAN PRIMARY CELLS
5.3 ANIMAL PRIMARY CELLS

6 MARKET, BY ORIGIN

6.1 OVERVIEW
6.2 HEMATOPOIETIC CELLS
6.3 LIVER CELLS
6.4 RENAL CELLS
6.5 SKIN CELLS
6.6 SKELETAL AND MUSCLE CELLS
6.7 OTHERS

7 MARKET, BY GEOGRAPHY

7.1 OVERVIEW
7.2 NORTH AMERICA
- 7.2.1 U.S.
- 7.2.2 CANADA
- 7.2.3 MEXICO
7.3 EUROPE
- 7.3.1 GERMANY
- 7.3.2 U.K
- 7.3.3 FRANCE
- 7.3.4 REST OF EUROPE
7.4 ASIA-PACIFIC
- 7.4.1 CHINA
- 7.4.2 JAPAN
- 7.4.3 INDIA
- 7.4.4 REST OF ASIA-PACIFIC
7.5 ROW
- 7.5.1 LATIN AMERICA
- 7.5.2 MIDDLE EAST AND AFRICA

8 COMPETITIVE LANDSCAPE

8.1 OVERVIEW
8.2 KEY DEVELOPMENT STRATEGIES
8.3 COMPANY MARKET RANKING ANALYSIS,

9 COMPANY PROFILES

9.1 MERCK KGAA
- 9.1.1 COMPANY OVERVIEW
- 9.1.2 COMPANY INSIGHTS
- 9.1.3 SEGMENT BREAKDOWN
- 9.1.4 PRODUCT BENCHMARKING
- 9.1.5 SWOT ANALYSIS
9.2 THERMO FISHER SCIENTIFIC
- 9.2.1 COMPANY OVERVIEW
- 9.2.2 COMPANY INSIGHTS
- 9.2.3 SEGMENT BREAKDOWN
- 9.2.4 PRODUCT BENCHMARKING
- 9.2.5 SWOT ANALYSIS
9.3 LONZA
- 9.3.1 COMPANY OVERVIEW
- 9.3.2 COMPANY INSIGHTS
- 9.3.3 SEGMENT BREAKDOWN
- 9.3.4 PRODUCT BENCHMARKING
- 9.3.5 SWOT ANALYSIS
9.4 CELL BIOLOGICS, INC.
- 9.4.1 COMPANY OVERVIEW
- 9.4.2 COMPANY INSIGHTS
- 9.4.3 PRODUCT BENCHMARKING
9.5 PROMOCELL
- 9.5.1 COMPANY OVERVIEW
- 9.5.2 COMPANY INSIGHTS
- 9.5.3 PRODUCT BENCHMARKING
9.6 AXOL BIOSCIENCES
- 9.6.1 COMPANY OVERVIEW
- 9.6.2 COMPANY INSIGHTS
- 9.6.3 PRODUCT BENCHMARKING
- 9.6.4 KEY DEVELOPMENT
9.7 STEMCELL TECHNOLOGIES INC
- 9.7.1 COMPANY OVERVIEW
- 9.7.2 COMPANY INSIGHTS
- 9.7.3 PRODUCT BENCHMARKING
9.8 BPS BIOSCIENCE, INC
- 9.8.1 COMPANY OVERVIEW
- 9.8.2 COMPANY INSIGHTS
- 9.8.3 PRODUCT BENCHMARKING
9.9 PPA RESEARCH GROUP, INC.
- 9.9.1 COMPANY OVERVIEW
- 9.9.2 COMPANY INSIGHTS
- 9.9.3 PRODUCT BENCHMARKING
- 9.9.4 KEY DEVELOPMENT
9.10 BIOPERDIC INTERNATIONAL
- 9.10.1 COMPANY OVERVIEW
- 9.10.2 COMPANY INSIGHTS
- 9.10.3 PRODUCT BENCHMARKING